Symbiosis II LLC sells CLNN shares (CLNN) across multiple open-market trades

Rhea-AI Filing Summary

Symbiosis II LLC reported multiple sales of Common stock of CLNN, recorded as open-market transactions. The excerpt lists individual dispositions by Symbiosis II LLC between 03/24/2026 and 05/04/2026, including notable trades of 67,991 shares on 03/31/2026 and 61,345 shares on 04/21/2026. The filing shows per-trade share counts and gross proceeds for each sale.

Insights

Securities Attorney

Form 144 lists affiliate/resale transactions and per-trade details.

Form 144 is a notice of proposed resale by an affiliate or control person. The excerpt provides transaction dates, share counts, and gross proceeds for each sale, which are the core disclosure items required for such notices.

Timing and settlement mechanics are not detailed in the excerpt; subsequent filings or broker records would show completion status.

Equity Capital Markets Analyst

Series of open-market dispositions by a single holder over several weeks.

The record lists many individual trades executed on Nasdaq via open-market sales with cash proceeds per trade. The pattern shows staged disposals rather than a single block trade.

Market impact and remaining holdings are not stated in the excerpt; the sales' significance depends on the holder's remaining position and company float.

Key Figures

Header share figure: 198,890 Sale on 03/31/2026: 67,991 shares Sale on 04/21/2026: 61,345 shares +2 more

5 metrics

Header share figure 198,890 listed under Securities Information near the cover section

Sale on 03/31/2026 67,991 shares trade dated <date>03/31/2026</date> with proceeds $332,103.67

Sale on 04/21/2026 61,345 shares trade dated <date>04/21/2026</date> with proceeds $376,718.05

Sale on 05/04/2026 41,260 shares one of two trades on <date>05/04/2026</date> with proceeds $270,381.15

Sale on 04/02/2026 24,925 shares trade dated <date>04/02/2026</date> with proceeds $119,855.20

Key Terms

Form 144, Open Market Purchase, Gross proceeds

3 terms

Form 144 regulatory

"lists individual dispositions and gross proceeds for proposed resale notices"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchase market

"Securities To Be Sold section identifies method as Open Market Purchase"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Gross proceeds financial

"each trade line pairs share counts with a dollar amount indicating proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	198890	1292785	11778307	05/11/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2024	Open Market Purchase	Issuer			198890	09/30/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/24/2026	5492	31722.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/25/2026	7098	39045.14
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/26/2026	5319	28705.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/27/2026	17470	82908.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/30/2026	15536	79283.66
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/31/2026	67991	332103.67
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/01/2026	4278	21254.31
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/02/2026	24925	119855.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/15/2026	6374	41300.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/16/2026	7748	49555.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/17/2026	25040	161097.44
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/20/2026	4318	26423.1
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/21/2026	61345	376718.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/28/2026	1591	9393.22
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/29/2026	12170	68561.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	04/30/2026	5736	34847.35
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	05/01/2026	5795	34837.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	05/04/2026	31624	225156.71
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	05/04/2026	41260	270381.15

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CLNN show?

It lists proposed open-market sales of CLNN common stock by Symbiosis II LLC. The excerpt provides dates, share counts, and gross proceeds for each sale between 03/24/2026 and 05/04/2026

How many shares did Symbiosis II LLC sell on 03/31/2026?

Symbiosis II LLC sold 67,991 shares on 03/31/2026. The excerpt shows that trade with gross proceeds of $332,103.67 recorded alongside the date and share count in the Form 144 listing.

What was the largest single trade listed in the excerpt?

The excerpt shows a 67,991-share sale on 03/31/2026 as one of the largest single trades. Other large trades include 61,345 shares on 04/21/2026 and multi‑day executions through 05/04/2026.

Does the Form 144 show who receives the sale proceeds?

The excerpt records gross proceeds per trade but does not specify recipients. Each line pairs shares with a dollar amount; the filing does not state whether proceeds go to the issuer or selling holder beyond the trade records.

Are the sales listed as open-market or another method?

The excerpt identifies the trades as open-market transactions. The securities section indicates "Open Market Purchase" method and per-trade cash proceeds, consistent with market execution entries.